| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
miR-324-5p, miR-326, miR-330-5p |
| Biological function: |
May participate in the pathogenesis and progress of NSCLC; potential biomarker/therapeutic target. |
| Molecular mechanism: |
Predicted miRNA sponge mechanism (in silico) targeting miR-324-5p, miR-326 and miR-330-5p; circRNA-miRNA-mRNA network analysis. |
| Biological pathway or process: |
ceRNA regulation (other); lipid metabolism (other); glycolysis (other); other pathway/process (other) |
| Detected method: |
Q
S
|
| Validation methods: |
RNA-seq; RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis |
| Clinical significance: |
Potential biomarker for NSCLC (circulating plasma). |
| Description: |
hsa_circ_0000722 is up-regulated in NSCLC patient plasma and was proposed as a circulating biomarker. Bioinformatic predictions suggest it may act as a miRNA sponge for miR-324-5p/miR-326/miR-330-5p and relate to cancer-associated pathways. |
| Confidence score: |
0.4032 |